Reddy PE
Departments of Biochemistry, Sri Venkateswara Institute of Medical Sciences, Tirupati- 517507, Andhra Pradesh, India

Manohar SM
Departments of Biochemistry, Sri Venkateswara Institute of Medical Sciences, Tirupati- 517507, Andhra Pradesh, India

Reddy SV
Departments of Biochemistry, Sri Venkateswara Institute of Medical Sciences, Tirupati- 517507, Andhra Pradesh, India

Bitla AR
Departments of Biochemistry, Sri Venkateswara Institute of Medical Sciences, Tirupati- 517507, Andhra Pradesh, India

Vishnubhotla S
Departments of Nephrology, Sri Venkateswara Institute of Medical Sciences, Tirupati- 517507, Andhra Pradesh, India

Lakshmi Narasimha SP
Departments of Biochemistry, Sri Venkateswara Institute of Medical Sciences, Tirupati- 517507, Andhra Pradesh, India

Correspondence:

Srinivasa Rao P.V Lakshmi Narasimha, M.D.
Department: Departments of Biochemistry, Sri Venkateswara Institute of Medical Sciences, Tirupati- 517507
Address: Department of Biochemistry, Sri Venkateswara Institute of Medical Sciences, Tirupati-517507, Andhra Pradesh, India
City: Andhra Pradesh
Country: India
E-mail: seenupvln@yahoo.com
Tel: +9849409066

1. Sarnak MJ, Levey AS, Schoolwerth AC, et al. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Hypertension. 2003;42:1050-65.

2. Zoccali C. Cardiovascular risk in uraemic patients-is it fully explained by classical risk factors? Nephrol Dial Transplant. 2000;15:454-7.

3. Miyazaki H, Matsuoka H, Itabe H, et al. Hemodialysis impairs endothelial function via oxidative stress: effects of vitamin E-coated dialyzer. Circulation. 2000;101:1002-6.

4. Steinberg D, Parthasarathy S, Carew T, Khoo J, Witztum J. Beyond cholesterol: modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med.1989;320:915-24.

5. Jackson P, Loughrey CM, Lightbody JH, McNamee PT, Young IS. Effect of hemodialysis on total antioxidant capacity and serum antioxidants in patients with chronic renal failure. Clin Chem. 1995;41:1135-8.

6. Massy ZA, Nguyen-Khoa T. Oxidative stress and chronic renal failure: markers and management. J Nephrol. 2002;15:336-41.

7. Wratten ML, Tetta C, Ursini F, Sevanian A. Oxidant stress in hemodialysis: prevention and treatment strategies. Kidney Int Suppl. 2000;76:126-32.

8. Nguyen AT, Lethias C, Zingraff J, Herbelin A, Naret C, Descamps-Latscha B. Hemodialysis membrane-induced activation of phagocyte oxidative metabolism detected in vivo and in vitro within microamounts of whole blood. Kidney Int. 1985;28:158-67.

9. Benzie IF, Strain JJ. The ferric reducing ability of plasma (FRAP) as a measure of "antioxidant power": the FRAP assay. Anal Biochem. 1996;239:70-6.

10. Ghiselli A, Serafini M, Natella F, Scaccini C. Total antioxidant capacity as a tool to assess redox status: critical view and experimental data. Free Radic Biol Med. 2000;29:1106-14.

11. Suresh DR, Silvia WD, Agarwal R. Lipid peroxidation and total antioxidant capacity in patients with chronic renal failure. Asian J Biochem. 2008;3:4.

12. Roob JM, Khoschsorur G, Tiran A, Horina JH, Holzer H, Winklhofer-Roob BM. Vitamin E attenuates oxidative stress induced by intravenous iron in patients on hemodialysis. J Am Soc Nephrol. 2000;11:539-49.

13. Handelman GJ, Walter MF, Adhikarla R, et al. Elevated plasma F2-isoprostanes in patients on long-term hemodialysis. Kidney Int. 2001;59:1960-6.

14. Nourooz-Zadeh J. Effect of dialysis on oxidative stress in uraemia. Redox Rep. 1999;4:17-22.

15. Ahmadpoor P, Eftekhar E, Nourooz-Zadeh J, Servat H, Makhdoomi K, Ghafari A. Glutathione,  glutathione-related enzymes, and total antioxidant capacity in patients on maintenance dialysis. Iran J Kidney Dis. 2009;3:22-7.

16. Rao P, Dakshinamurty K, Saibaba K, et al. Oxidative stress in haemodialysis-intradialytic changes.  edox Rep. 2001;6:303-9.

17. Weinstein T, Chagnac A, Korzets A, et al. Haemolysis in haemodialysis patients: evidence for impaired defence mechanisms against oxidative stress. Nephrol Dial Transplant. 2000;15:883-7.

18. Sangeetha P, Das U, Koratkar R, Suryaprabha P. Increase in free radical generation and lipid peroxidation following chemotherapy in patients with cancer. Free Radic Biol Med. 1990;8:15-9.

19. Bolton CH, Downs LG, Victory JG, et al. Endothelial dysfunction in chronic renal failure: roles of  ipoprotein oxidation and pro-inflammatory cytokines. Nephrol Dial Transplant. 2001;16:1189-97.

20. Gazdikova K, Gvozdjakova A, Kucharska J, Spustova V, Braunova Z, Dzurik R. Malondialdehyde and selected antioxidant plasma levels in conservatively treated patients with kidney diseases. Bratisl Lek Listy. 2000;101:490-4.

21. Mircescu G, Capu C, Stoian I, Vargolici B, Barbulescu C, Ursea N. Global assessment of serum antioxidant status in hemodialysis patients. J Nephrol. 2005;18:599-605.

22. Gutteridge J, Rowley D, Halliwell B. Superoxide-dependent formation of hydroxyl radicals and lipid peroxidation in the presence of iron salts. Detection ofcatalytic'iron and anti-oxidant activity in extracellular fluids. Biochem J. 1982;206:605-9.

23. Foy CJ, Passmore AP, Vahidassr MD, Young IS, Lawson JT. Plasma chain-breaking antioxidants in Alzheimer's disease, vascular dementia and Parkinson's disease. QJM. 1999;92:39-45.

24. Sevanian A, Davies KJ, Hochstein P. Serum urate as an antioxidant for ascorbic acid. Am J Clin Nutr. 1991;54:1129-1134.

25. Whitehead T, Jungner I, Robinson D, Kolar W, Pearl A, Hale A. Serum urate, serum glucose and diabetes. Ann Clin Biochem. 1992;29:159-61.

26. Cao G, Prior RL. Comparison of different analytical methods for assessing total antioxidant capacity of human serum. Clin Chem. 1998;44:1309-15.

27. Gerardi G, Usberti M, Martini G, et al. Plasma total anti- oxidant capacity in hemodialyzed patients and its relationships to other biomarkers of oxidative stress and lipid peroxidation. Clin Chem Lab Med. 2002;40:104-10.

28. Malliaraki N, Mpliamplias D, Kampa M, Perakis K, Margioris A, Castanas E. Total and corrected antioxidant capacity in hemodialyzed patients. BMC Nephrol. 2003;4:4.

29. Abuja PM. Ascorbate prevents prooxidant effects of urate in oxidation of human low density lipoprotein. FEBS Lett. 1999;446:305-8.